Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 10 | uM | 7 | 156.25 | 28.40 | 84.00 | 126.75 | 0.6627 | 0.6529 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 156.25 | 28.40 | 58.00 | 126.75 | 0.4576 | 0.3923 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 156.25 | 28.40 | 142.00 | 126.75 | 1.1203 | 1.1081 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 156.25 | 28.40 | 58.00 | 126.75 | 0.4576 | 0.3923 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 156.25 | 28.40 | 166.00 | 126.75 | 1.3097 | 1.2663 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 156.25 | 28.40 | 168.00 | 126.75 | 1.3254 | 1.2789 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 160.00 | 126.75 | 1.2623 | 1.2280 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 136.00 | 126.75 | 1.0730 | 1.0664 | |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 156.25 | 28.40 | 127.00 | 126.75 | 1.0020 | 1.0018 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 136.00 | 126.75 | 1.0730 | 1.0664 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 156.25 | 28.40 | 93.00 | 126.75 | 0.7337 | 0.7327 |
| BT-20 | Erlotinib | 1 | uM | 7 | 156.25 | 28.40 | 171.00 | 126.75 | 1.3491 | 1.2977 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 156.25 | 28.40 | 85.00 | 126.75 | 0.6706 | 0.6620 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 156.25 | 28.40 | 91.00 | 126.75 | 0.7180 | 0.7154 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 122.00 | 126.75 | 0.9625 | 0.9649 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 156.25 | 28.40 | 46.00 | 126.75 | 0.3629 | 0.2505 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 96.00 | 126.75 | 0.7574 | 0.7584 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 2.00 | 126.75 | 0.0158 | -0.7075 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 4.00 | 126.75 | 0.0316 | -0.5967 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 142.00 | 126.75 | 1.1203 | 1.1081 | |
| BT-20 | 17-AAG | 10 | uM | 7 | 156.25 | 28.40 | 51.00 | 126.75 | 0.4024 | 0.3117 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 156.25 | 28.40 | 75.00 | 126.75 | 0.5917 | 0.5683 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 156.25 | 28.40 | 141.00 | 126.75 | 1.1124 | 1.1012 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 156.25 | 28.40 | 153.00 | 126.75 | 1.2071 | 1.1823 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 129.00 | 126.75 | 1.0178 | 1.0164 |